Baudax Bio, Inc.
OTC: BXRXQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gerri Henwood
- Employees
- 9
- Headquarters
- Malvern, United States
- IPO year
- 2019
- Market cap
- $4.4K
- Website
- https://www.baudaxbio.com
Loading BXRXQ…
Loading profile data…Frequently asked questions about BXRXQ
What does Baudax Bio, Inc. (BXRXQ) do?
Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops...
Where does BXRXQ trade?
Baudax Bio, Inc. (BXRXQ) trades on the Other OTC.
What sector is BXRXQ in?
Baudax Bio, Inc. (BXRXQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Baudax Bio, Inc.?
Gerri Henwood is the chief executive officer of Baudax Bio, Inc. (BXRXQ).
Where is Baudax Bio, Inc. headquartered?
Baudax Bio, Inc. is headquartered in United States.
Does BXRXQ pay a dividend?
Baudax Bio, Inc. (BXRXQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BXRXQ go public?
Baudax Bio, Inc. (BXRXQ) completed its initial public offering in 2019.